INVACARE CORP (IVC) Fundamental Analysis & Valuation

NYSE:IVC • US4612031017

Current stock price

0.6598 USD
-0.02 (-2.25%)
At close:
0.53 USD
-0.13 (-19.67%)
Pre-Market:

This IVC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IVC Profitability Analysis

1.1 Basic Checks

  • In the past year IVC has reported negative net income.
  • In the past year IVC has reported a negative cash flow from operations.
IVC Yearly Net Income VS EBIT VS OCF VS FCFIVC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

  • IVC has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVC Yearly ROA, ROE, ROICIVC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -5 -10 -15 -20

1.3 Margins

  • IVC's Gross Margin of 24.21% is on the low side compared to the rest of the industry. IVC is outperformed by 77.78% of its industry peers.
  • IVC's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for IVC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.24%
IVC Yearly Profit, Operating, Gross MarginsIVC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 10 20

1

2. IVC Health Analysis

2.1 Basic Checks

  • IVC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IVC has been increased compared to 1 year ago.
  • IVC has a worse debt/assets ratio than last year.
IVC Yearly Shares OutstandingIVC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
IVC Yearly Total Debt VS Total AssetsIVC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

2.2 Solvency

  • IVC has an Altman-Z score of 0.90. This is a bad value and indicates that IVC is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.90, IVC is in line with its industry, outperforming 47.22% of the companies in the same industry.
  • A Debt/Equity ratio of 4.82 is on the high side and indicates that IVC has dependencies on debt financing.
  • IVC's Debt to Equity ratio of 4.82 is on the low side compared to the rest of the industry. IVC is outperformed by 88.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF N/A
Altman-Z 0.9
ROIC/WACCN/A
WACC5.71%
IVC Yearly LT Debt VS Equity VS FCFIVC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that IVC should not have too much problems paying its short term obligations.
  • IVC's Current ratio of 1.32 is on the low side compared to the rest of the industry. IVC is outperformed by 85.65% of its industry peers.
  • A Quick Ratio of 0.78 indicates that IVC may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.78, IVC is doing worse than 87.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.78
IVC Yearly Current Assets VS Current LiabilitesIVC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

1

3. IVC Growth Analysis

3.1 Past

  • The earnings per share for IVC have decreased strongly by -137.21% in the last year.
  • The Revenue has decreased by -9.61% in the past year.
  • IVC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.59% yearly.
EPS 1Y (TTM)-137.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-666.67%
Revenue 1Y (TTM)-9.61%
Revenue growth 3Y-3.55%
Revenue growth 5Y-3.59%
Sales Q2Q%-23.99%

3.2 Future

  • IVC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.14% yearly.
  • IVC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.30% yearly.
EPS Next Y-309.94%
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue Next Year-16.76%
Revenue Next 2Y-8.92%
Revenue Next 3Y-0.3%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IVC Yearly Revenue VS EstimatesIVC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
IVC Yearly EPS VS EstimatesIVC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2 -2.5

0

4. IVC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IVC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVC Price Earnings VS Forward Price EarningsIVC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVC Per share dataIVC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.08%
EPS Next 3Y1.14%

0

5. IVC Dividend Analysis

5.1 Amount

  • IVC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IVC Fundamentals: All Metrics, Ratios and Statistics

INVACARE CORP

NYSE:IVC (1/31/2023, 8:04:00 PM)

Premarket: 0.53 -0.13 (-19.67%)

0.6598

-0.02 (-2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07
Earnings (Next)03-06
Inst Owners0%
Inst Owner Change0%
Ins Owners8.6%
Ins Owner Change0%
Market Cap24.91M
Revenue(TTM)786.60M
Net Income(TTM)-78.56M
Analysts83.33
Price Target1.68 (154.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-90.87%
Min EPS beat(2)-135.57%
Max EPS beat(2)-46.16%
EPS beat(4)1
Avg EPS beat(4)19.93%
Min EPS beat(4)-135.57%
Max EPS beat(4)296.04%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-12.25%
Min Revenue beat(2)-14.37%
Max Revenue beat(2)-10.12%
Revenue beat(4)1
Avg Revenue beat(4)-7.59%
Min Revenue beat(4)-14.37%
Max Revenue beat(4)0.78%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-49.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-111.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.5%
Revenue NQ rev (1m)-1.36%
Revenue NQ rev (3m)-14.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.55%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.04
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.65
OCFYN/A
SpS20.83
BVpS2.15
TBVpS-6.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.24%
F-Score3
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 4.82
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.78
Altman-Z 0.9
F-Score3
WACC5.71%
ROIC/WACCN/A
Cap/Depr(3y)110.34%
Cap/Depr(5y)98.77%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-137.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-666.67%
EPS Next Y-309.94%
EPS Next 2Y-41.08%
EPS Next 3Y1.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.61%
Revenue growth 3Y-3.55%
Revenue growth 5Y-3.59%
Sales Q2Q%-23.99%
Revenue Next Year-16.76%
Revenue Next 2Y-8.92%
Revenue Next 3Y-0.3%
Revenue Next 5YN/A
EBIT growth 1Y-4083.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-562.49%
EBIT Next 3Y89.23%
EBIT Next 5Y54.07%
FCF growth 1Y-151.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-397.05%
OCF growth 3YN/A
OCF growth 5YN/A

INVACARE CORP / IVC Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INVACARE CORP?

ChartMill assigns a fundamental rating of 2 / 10 to IVC.


What is the valuation status of INVACARE CORP (IVC) stock?

ChartMill assigns a valuation rating of 3 / 10 to INVACARE CORP (IVC). This can be considered as Overvalued.


Can you provide the profitability details for INVACARE CORP?

INVACARE CORP (IVC) has a profitability rating of 1 / 10.


Can you provide the dividend sustainability for IVC stock?

The dividend rating of INVACARE CORP (IVC) is 0 / 10 and the dividend payout ratio is 0%.